Inovio Pharmaceuticals
INO
#8848
Rank
ยฃ0.11 B
Marketcap
ยฃ1.63
Share price
0.46%
Change (1 day)
-48.33%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): -ยฃ2.15

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -ยฃ2.15. In 2024 the company made an earnings per share (EPS) of -ยฃ2.95 an increase over its 2023 EPS that were of -ยฃ4.55.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-ยฃ2.15-27.13%
2024-ยฃ2.95-35.14%
2023-ยฃ4.55-56.62%
2022-ยฃ10.49-19.54%
2021-ยฃ13.0435.9%
2020-ยฃ9.60-11.57%
2019-ยฃ10.8515.24%
2018-ยฃ9.42-2.78%
2017-ยฃ9.696.93%
2016-ยฃ9.06134.88%
2015-ยฃ3.86-29.51%
2014-ยฃ5.47-57.34%
2013-ยฃ12.83146.55%
2012-ยฃ5.2020.83%
2011-ยฃ4.31-29.41%
2010-ยฃ6.10-48.48%
2009-ยฃ11.8410%
2008-ยฃ10.7611.11%
2007-ยฃ9.69-41.3%
2006-ยฃ16.50-66.91%
2005-ยฃ49.87110.61%
2004-ยฃ23.68-61.63%
2003-ยฃ61.71186.67%
2002-ยฃ21.53
2001N/A-100%
2000-ยฃ17.22-63.64%
1999-ยฃ47.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
ยฃ1.29-159.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ7.80-462.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-ยฃ0.93-56.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ5.50-355.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
ยฃ5.68-363.67%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ2.69-224.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
ยฃ4.87-326.39%๐Ÿ‡บ๐Ÿ‡ธ USA